Multiple Research Results from Innovent's General Biomedicine Pipeline Showcased at 2025 ACR Annual Meeting

Multiple Research Results from Innovent's General Biomedicine Pipeline Showcased at 2025 ACR Annual Meeting

SAN FRANCISCO and SUZHOU, China, Nov. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major…

Incytes Hematology Breakthroughs to Take Center Stage at ASH 2025 Over 50 Abstracts Accepted,

'Incyte Set to Shine at ASH Annual Meeting 2025 with Over 50 Accepted Abstracts Focused on Advancements in Hematology' Incyte Corporation (Nasdaq: INCY), a leading biopharmaceutical company, has announced the acceptance of over 50 summaries (abstracts) for presentation at the Annual Meeting of the American Society of Hematology (ASH) set to be held from December 6 to 9, 2025, in Orlando, Florida. This impressive number not only highlights Incyte…